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Abstract
Background: Electronic medical records (EMR) offer a major potential for secondary use of data for research which
can improve the safety, quality and efficiency of healthcare. They also enable the measurement of disease burden
at the population level. However, the extent to which this is feasible in different countries is not well known. This
study aimed to: 1) assess information governance procedures for extracting data from EMR in 16 countries; and 2)
explore the extent of EMR adoption and the quality and consistency of EMR data in 7 countries, using management of
diabetes type 2 patients as an exemplar.
Methods: We included 16 countries from Australia, Asia, the Middle East, and Europe to the Americas. We undertook
a multi-method approach including both an online literature review and structured interviews with 59 stakeholders,
including 25 physicians, 23 academics, 7 EMR providers, and 4 information commissioners. Data were analysed and
synthesised thematically considering the most relevant issues.
Results: We found that procedures for information governance, levels of adoption and data quality varied across the
countries studied. The required time and ease of obtaining approval also varies widely. While some countries seem
ready for secondary uses of data from EMR, in other countries several barriers were found, including limited experience
with using EMR data for research, lack of standard policies and procedures, bureaucracy, confidentiality, data security
concerns, technical issues and costs.
Conclusions: This is the first international comparative study to shed light on the feasibility of extracting EMR data
across a number of countries. The study will inform future discussions and development of policies that aim to
accelerate the adoption of EMR systems in high and middle income countries and seize the rich potential for
secondary use of data arising from the use of EMR solutions.
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Background
Characteristics and benefits of electronic medical records
(EMR)
Electronic medical records (EMR) offer a major potential to
improve the safety, quality and efficiency of healthcare [1].
The International Organisation for Standardization defines
EMR (often referred to as electronic health or patient re-
cords, computerised medical or patient records and Elec-
tronic Health Record) as a “repository of information
regarding the health status of a subject of care, in computer
processable form” [2]. Thus, EMRs are an electronic ver-
sion of patients’ health records which can be used for
input, storage, display, retrieval and sharing of infor-
mation [3]. Accurate and complete data from EMRs
can be used by practitioners to improve the safety,
quality and efficiency of care. For example, EMRs have
been used to provide physicians with data regarding
type 2 diabetic patients, which has shown to improve
process measures such as an increased number of foot
and eye check-ups and biological outcomes including
glycated haemoglobin (known as “HbA1c”) and blood
glucose [4].
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There are several secondary uses of data from EMR
that can improve healthcare services, including popula-
tion and disease research, detection of adverse drug
reactions, assessment of outcomes of interventions,
shaping health policies, and guidance on effective use of
resources [5–7]. EMR data can be an indispensable
source for population and disease research especially
when it can be linked with mortality records and genetic
data. Data can be made available for research through
different mechanisms; for example in the United Kingdom,
large primary care databases, the Clinical Practice Research
Datalink system [8], the Health Improvement Network [9]
and QResearch [10], provide access to National Health
Service observational data and interventional research. This
data is used for various areas of research including, cardio-
vascular disease, mental health and pharmacoepidemiology
[9]. EMR data are also invaluable to the pharmaceutical in-
dustry which, for example, can use data to improve the
safety of medication use by monitoring side-effects and in-
teractions with other medication [11]. A major potential
benefit of secondary data analysis of EMR data is its use to
improve global burden of disease measurement, especially,
though not exclusively, of non-communicable diseases [12].
Barriers to secondary use of EMR data
Despite the large investments in EMR systems world-
wide, some countries have yet to realise the potential of
EMR to improve the quality, safety and efficiency of
healthcare [13, 14]. In many settings, electronically col-
lected data is often not analysed at aggregate level, which
limits our understanding regarding a population’s health
needs, disease management, quality of management of
chronic conditions and outcomes of interventions at
both primary care and hospital settings [5]. There are
several barriers constraining the potential of EMR data
for secondary uses. An important barrier in some cases is
the poor accuracy and completeness of EMR data [15, 16].
Other barriers include legal and ethical considerations re-
quired for secondary use of EMR data [7]. Information
governance procedures can be a barrier as obtaining ap-
provals to extract and analyse EMR data may be challen-
ging given the novelty of this type of research in certain
countries. Moreover, the diversity in EMR systems across
different settings and differences in legal and information
governance systems, social norms and frameworks pose
additional challenges for obtaining approvals. Therefore,
identifying and addressing current barriers towards sec-
ondary use of EMR data is of great importance to facilitate
greater use of EMR solutions.
State of EMR adoption internationally
Currently, there is limited evidence on the adoption of
EMR internationally [5, 17]. Previous assessments have
mainly focussed on the adoption of EMR systems in the
United States and some other countries [4, 17–21]. A re-
cent systematic review on the impact of EMR implemen-
tations found that nearly two-thirds of EMR studies took
place in the United States (n = 62), a small number of
studies were conducted in England and Denmark (n = 5),
Canada (n = 3), and Norway (n = 4), and an even smaller
number (n = 1–2) in other countries [17]. Moreover,
according to the same review, there have been few inter-
national comparisons of EMR [17]; the review found only
one paper comparing EMR implementations between
countries (United States and Sweden) [22]. Given the
novelty of using data from EMR in some countries, infor-
mation regarding ethical and legal procedures that are
required is also scarce.
Aim of this study
This study aimed to assess information governance pro-
cedures for extracting data from EMR across 16 coun-
tries, using the management of type 2 diabetic patients
as an exemplar. A secondary aim of the study was to
explore the extent of EMR adoption and the quality and
consistency of EMR data in 7 countries. Thereby, this
study identifies barriers towards secondary uses of EMR
data across different countries, which can be used to
facilitate future analysis of EMR data.
Methods
Overview
This international comparative study covered 16 countries
(Table 1). We assessed the adoption of EMR, quality of
their data in 7 countries, Brazil, Italy, South Africa, Saudi
Arabia, Korea, Rep., Taiwan and United Arab Emirates
(UAE), and information governance processes for second-
ary uses of data in all 16 countries.
This study was commissioned by IMS Health (http://
www.imshealth.com/) and they chose the countries and de-
veloped the questionnaires. The countries were selected
for a planned non-interventional study, which included
type 2 diabetes mellitus patients. The selection of countries
was made based on preliminary expert advice and know-
ledge whether countries had a reasonable level of EMR
adoption and limited fragmentation of EMR providers.
The typical treatment settings for type 2 diabetes patients
were general physicians and specialists in hospitals, but
varied between countries (Additional files 1 and 2).
The study had a multi-method design which included
peer-reviewed and grey literature review, email contact with
relevant experts in countries studied and interviews with
key stakeholders to collect information on governance pro-
cesses, EMR adoption and data quality. We sought to iden-
tify the authorities and assess processes for approval of
EMR data extraction and use for research, approximate
time needed to obtain all approvals and expected ease of
obtaining approval. We also examined the adoption of
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EMR systems within relevant treatment settings, EMR data
quality, which was defined as typical fields covered, average
fill rate (percentage of visits in which clinical information,
including patient information, vitals, diagnosis, prescription,
procedures, lab test results and patient behavioural, is being
filled) and fields with close-ended questions, details of elec-
tronic health record systems, as well as trend and incentives
on EMR use.
Literature review
We conducted a literature review on academic papers
using EMR data from type 2 diabetic patients, as well as
other EMR extracted data (a description of the literature
on adoption of EMR in the countries can be found in
Additional file 3). Sources of information included scien-
tific databases (e.g. PubMed and Google Scholar). Search
terms included: electronic medical record*; Electronic
Health Records [MeSH]; electronic health record*; elec-
tronic patient record*; computer-based or computerised
medical record; computer-based or computerised health
record; computer-based or computerised patient record;
country name; and diabetes. Other optional terms in-
cluded: adoption, uptake, coverage, governance, trend*,
ethic*, and provider*. Where possible, we conducted
more general literature searches (e.g. on Ministry of
Health and EMR provider websites) to find additional
information and contacts for the interviews. We included
studies that reported on at least one of the following as-
pects of EMR: information governance procedures for
extracting data from EMR; EMR adoption; and the quality
and consistency of EMR data.
Interviews
A structured interview questionnaire was used that in-
cluded questions on: treatment setting of type 2 diabetes
patients and EMR adoption within treatment settings;
use of EMR data and existing relationships with EMR
providers; information governance; trends and incentives
on EMR use; and details of EMR systems. Contact
details of interviewees were compiled through academic
connections, contacting authors of literature review pub-
lications, searching the internet for research centres,
hospitals, diabetes clinics and centres, specialists (diabe-
tologists/endocrinologists) and contacting national and
international diabetes organisations. Contacts were a
mix of public and private sector professionals, including
family practitioners and specialists with an emphasis on
individuals in the field of diabetes, EMR providers, aca-
demics and information commissioners.
We requested interviews via phone and/or email. All
interviewees were informed about the study and pro-
vided consent to participate (verbal for telephone calls
and written for email). Five trained interviewers con-
ducted phone interviews with participants from each
country in English, apart from one interview that was
conducted in Polish and transcribed verbatim and trans-
lated to English by a speaker native in both the English
and Polish language. This was a rapid-response survey
and due to time and/or language barriers, a small num-
ber of questionnaires were self-completed and sent via
email. The number of conducted interviews ranged from
1 to 7 per country, depending on the availability of par-
ticipants and the information required. We also engaged
Table 1 The scope of assessment of countries included in this study
Country Scope of assessmenta Region [49] Income level [50]
Saudi Arabia Full assessment Eastern Mediterranean High-income
United Arab Emirates (UAE) Full assessment Eastern Mediterranean High-income
Taiwan Full assessment Western Pacific High-income
Korea, Rep. Full assessment Western Pacific High-income OECD
Italy Full assessment European High-income OECD
South Africa Full assessment African Upper-middle-income
Brazil Full assessment Americas Upper-middle-income
Australia Information governance Western Pacific High-income OECD
Austria Information governance European High-income OECD
Czech Republic Information governance European High-income OECD
The Netherlands Information governance European High-income OECD
Poland Information governance European High-income OECD
China Information governance Western Pacific Upper-middle-income
Mexico Information governance Americas Upper-middle-income
India Information governance South-East Asia Lower-middle-income
Indonesia Information governance South-East Asia Lower-middle-income
aFull assessment entails adoption of EMR, quality of their data and information governance processes
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with those who provided information to self-assess reli-
ability and comprehensiveness of information as an
additional guide whether to seek further sources of
information. We invited 377 informants and 59 partici-
pants were interviewed. Some participants were identi-
fied through expert referral and therefore we are unable
to provide the exact number of those invited and those
who declined participation. Of those who declined, some
were unable to provide relevant information and others
did not have time for participation in the study. Our
purposive sample of 59 participants consisted of the
following: 25 physicians, 23 academics, 7 EMR pro-
viders, and 4 information commissioners (Additional file
4). Interview data were analysed thematically. Two re-
searchers read through the interview transcripts several
times in an active way (searching for meaning) and gave
initial codes to findings (units of texts). Then they
searched for themes and sorted codes into themes. To
verify the data, the results were shared with the research
team and discussed.
Data synthesis
We synthesised all information from the literature re-
view documents and interview questionnaires thematic-
ally (Additional files 1 and 2). When large discrepancies
in conflicting information (e.g. time to obtain approval)
were found, we provided a range i.e. min to max. When
only small discrepancies in conflicting information were
found, we provided an average. Other conflicts of infor-
mation were resolved by consensus among the team
members, with a tendency towards the more trustworthy
and competent source of information (assessment of
those based on personal impressions).
Results
Information governance processes
Authorities and processes for approval for EMR data
extraction and use for research
We obtained information regarding processes to obtain
approval for EMR data extraction for research purposes
in all countries apart from Austria where data from
EMR systems were not yet meant to be used for research
(Additional file 1). The procedures for obtaining ap-
provals varied highly between countries. Approval pro-
cesses varied significantly even between European
countries. However, typically the different authorities
from which approval had to be obtained to allow extrac-
tion of data from EMRs included ethics committees
(health facility and/or regional or national boards), sites
where data was collected, and national, regional or local
health authorities. Additional approvals were needed
from EMR providers in certain countries (Australia,
Czech Republic, Italy, India, Poland and South Africa).
There were also differences in approval procedures
between different geographical areas within a number of
countries (China [see information governance procedures
described in Table 2], the Czech Republic, Indonesia, Italy,
India, South Africa and UAE).
Additional approvals had to be obtained for data from
the private sector in two countries (Australia, Poland).
In addition, the approval procedures varied according to
the type of study; for example, in Italy, participants said
that a simple notification to the ethics board was needed
for retrospective studies, while formal approval from the
health authority was needed for prospective studies. In-
dividual patient consent was often not required for
anonymised data with the exception of South Africa
where patient consent was always required. In some
countries, obtaining patient consent was usual practice,
though not necessary (Italy, the Netherlands).
Approximate time needed to obtain all approvals
The approximate time to obtain all the approvals that
were required for extracting data from EMR highly
varied. In 7 countries, the average time was between 3
and 6 months (Czech Republic, India, Indonesia, the
Netherlands, Poland, Korea, Rep., UAE), whilst in 5 coun-
tries between 6 months and 1 year (Australia, Brazil, Italy,
Mexico, Saudi Arabia). The time was expected to be less
than 3 months for China, while variable times were reported
for Taiwan (between 3 months and 6 years). In South Africa,
an unsuccessful attempt for obtaining approvals lasted be-
tween 1 and 2 years. Typically the process could be lengthy
and the time needed was dependent on the number of
different sites that were to be included in a study.
Ease of obtaining approval
For most countries it was thought that obtaining ap-
proval was moderately easy. The exceptions were India
and South Africa where this was difficult, as no standard
procedures were in place to obtain approval, and Austria
where obtaining approval was currently not feasible be-
cause of legal barriers.
The barriers to obtaining approvals were: (i) the nov-
elty of using data from EMR for research, (ii) lack of
standard procedures, (iii) bureaucracy, (iv) confidential-
ity, (v) technical issues and (vi) costs. Firstly, in some
countries, there was little previous experience with con-
ducting research using data from EMR (India, Indonesia,
South Africa and Saudi Arabia). In another country,
showing that a study had a real benefit to the health
facility and public was reported to make approval proce-
dures easier (Brazil). Secondly, a lack of uniformity of
rules and regulations or policies for EMR data extraction
was a challenge for obtaining approvals in three coun-
tries (China, India and South Africa). Sometimes, cer-
tain individuals had to be involved to obtain approval
(South Africa, China); for example, one respondent said
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that in China the director of the hospital plays a key
role in the approval procedure. Thirdly, the process was
lengthier and more complex because of the need for
approvals from: multiple organisations (Australia, Brazil,
Korea, Rep., Taiwan, India), different levels within organi-
sations (South Africa) and different stakeholders (India).
One participant also mentioned that there were frequently
delays in responses to approval requests (South Africa).
Fourthly, there was a reluctance to share data because of
concerns about confidentiality (Italy, Mexico), data secur-
ity (Poland), and data leakage (China), which stressed the
importance of developing trust to gain access to the data.
Fifthly, technical issues, such as lack of interoperability
(South Africa), limited bandwidth (UAE), difficulty with
de-identification of data (Australia, Czech Republic) and
identification of the correct EMR (India), were also men-
tioned as common barriers. These were challenging
because there was a need for information technology spe-
cialists, but lack of experience and poor literacy among
staff (South Africa). Finally, respondents considered the
cost of administration (China), patents, utilisation and
licensing (South Africa) and negotiating prices with
EMR providers (Korea, Rep.) as additional barriers to
obtaining approval.
Adoption and quality of EMR
EMR adoption
EMR adoption was examined in 7 countries. Overall, Italy,
Saudi Arabia, Korea, Rep., Taiwan and UAE had high EMR
adoption rates while Brazil and South Africa had lower
rates. However, EMR adoption rates were variable between
different settings within countries (Additional file 2). In
UAE, almost 100 % of Health Authority of Abu Dhabi
(HAAD) affiliated healthcare facilities, known as Abu
Dhabi Health Services Company (SEHA), had an EMR
system. In Italy and Korea, Rep., around 90 % of general
physician clinics used an EMR. However, in Italy, adop-
tion rates varied between different regions and hospi-
tals. In Korea, Rep., almost 80 % of tertiary hospitals
and 40 % of smaller hospitals had an EMR. Finally, in
Taiwan, all large medical centres (>1000 beds), approxi-
mately 70 % of regional hospitals and almost 30 % of
district hospitals used an EMR.
The quality of EMR data and details on EMR systems
In six of these countries (excluding Brazil, see the full
assessment described in Table 3), typical fields cov-
ered in EMR systems were: patient information, pa-
tient vital signs, diagnoses, prescriptions, information
Table 2 EMR information governance: the example of China
Authorities who need to provide approval for EMR
extraction and use of data for research purpose
• Ethics boards within the hospitals.
• National and local health authorities e.g. Division of Medical Affairs and Division of Research:
necessary if retrieving data from various provinces, or retrieving national data of various kinds
such as public health, immunisation or epidemiology of emergency events.
• Site where the data was collected: director of the hospital, hospital data centre.
• Individual patients: In Hong Kong Special Administrative Region (HKSAR) consent needed for
access to EHR. Not conclusive if required in mainland China.
• In HKSAR: the Office of the Privacy Commissioner for Personal Data, an independent statutory
body, oversees enforcement of the Personal Data Privacy Ordinance (PDPO). Although not
applicable for anonymised data, users should comply with requirements under the PDPO
personal data handling. Suspected breaches will be investigated.
Process to obtain approval • Submission of Case Report Form (to ascertain potential harm to patients) and research proposal.
• However, there is no clear legal framework about data use rights.
• Process for Hong Kong:
1. Application to the Secretary for Food and Health;
2. The Secretary for Food and Health may refer application to the Electronic Health Record
Research Board;
3. The Board must consider several factors including ethical issues and public interest;
4. Applications for non-identifiable data are made to the Commissioner for Electronic Health
Records (eHRC).
Approximate time needed to obtain all approvals Less than 3 months.
Ease of obtaining approval Relatively easy, as there are procedures in place and the process is quick.
The director of the hospital plays a key role in the approval process.
Hurdles:
• Organisation of the administration (no specific rules and regulations for data extraction).
• Potential technical problems at some sites due to own systems in hospitals, and concerns
of data leakage in China.
• Law prohibiting transfer of non-anonymised EMR data outside HKSAR (section 33 of the PDPO),
but not in force yet.
• Anonymised patient data can be used for research and preparing statistics relevant to public
health or public safety if conditions for approval by the future Commissioner for the EHR under
Division 3 of the eHRSS Bill are fulfilled.
Regional differences Regional differences exist, e.g. Hong Kong has own authority dedicated to data protection.
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about hospitalisations, procedures/tests performed and
lab test results. Average fill rates were reported to be
high (75–100 %). The fields that were closed-ended
were less clearly described and varied between set-
tings. In Brazil, there was very little information re-
garding the fields and fill rates as this highly varied
between clinics. Although it was possible to link in-
formation with systems from other sites in most
countries (Italy, South Africa, Taiwan, UAE, Saudi
Arabia), sometimes this was only for certain informa-
tion, such as prescriptions, procedures performed and
lab test results (Saudi Arabia).
Trend and incentives in EMR use
Overall, the trend for adoption of EMR was increasing
in all 7 countries, but this was a slow process. Govern-
ment incentives were poor in Brazil, but present in all
other countries where EMR implementation was seen as
a necessity to improve health services. However, EMR
providers had a large interest to expand EMR adoption
in Brazil’s large market.
Discussion
This study adds important novel insights into the feasi-
bility of extracting EMR data for research in 16 high–
and middle-income countries. We assessed information
governance processes and EMR adoption and quality in
several countries for which no previous information in
academic literature was available. We also examined dif-
ferent countries compared to previous EMR assessments
[4, 17–21]. Thereby, this study identified barriers towards
secondary uses of EMR data in different countries that
can be used to inform future EMR data analysis.
We found that obtaining approval for extracting data
from EMR for research was moderately easy in most of
the 16 countries for which we assessed information
governance procedures. Exceptions were India and
South Africa where obtaining approval was difficult and
Austria where obtaining approval was currently not
feasible as data from EMR were not yet meant to be
used for secondary purposes.
Our study found a mix of different levels of EMR
adoption and data quality across the seven countries that
Table 3 EMR adoption, data quality, implementation trends and incentives: the example of Brazil
Typical treatment settings for type 2
diabetes patients
• All basic care outside hospitals.
• Public system is represented by public clinics (general physicians and specialists). Limited access to medication,
usually low cost drugs given, dispensing often not recorded.
• Private system (25 % of Brazilian population) consists of specialist physicians’ offices clinics. This is where
most drug consumption takes place.
EMR adoption rate in the typical
treatment setting
• Highly varied responses: general physicians 5–40 %, Specialists 5–50 %, Hospitals 7–80 %, Emergency
units 50 %. Difficult to capture as it depends on each physician and office.
• Low overall adoption.
• Primary reason for reluctance to EMR and persistent paper culture: concerns among healthcare institutions
regarding the security of patient data/concept of physicians owning their patient data and not wanting to
forward this to other physicians.
Typical fields covered in the EMR system • Depends on the type and structure of the system used by physician. This would be a clinic by clinic exercise.
• No electronic prescriptions.
• Both public and private hospitals (providing public services) have central database for claims data: only
high-cost procedures and high-cost drugs dispensed.
• More data captured in public system as attended by different physicians each time (EMR more favourable).
Average fill rate Difficult to capture. This would be a clinic by clinic exercise.
Fields with close-ended questions As physicians are protective of patient data, open fields may be more common than closed-ended. Some
niche specialised systems exist with parameters used by the type of specialist, perhaps more likely to have
close-ended questions.
Overall trend on EMR implementation • Trend is growing and expanding slowly.
• All initiatives are confined to private market.
• No large changes in regulations or government mandatory imposed policy that will make change
happen faster.
• However, much interest from EMR vendors and accelerating activity expected in the next few years expected
as Brazil is the third largest world market for EMR: with >200 million inhabitants, >7000 hospitals, >300,000
physicians, and a mixed public and private healthcare system.
• The EMR market earned revenues of US $145 million in 2012 and estimates to reach US $336 million in
2018 at a compound annual growth rate of 15 percent.
Incentives for EMR implementation • Most important incentive is the necessity to improve services and coordination of care as public and
private health sectors are stretched. Likely to follow other countries in EMR implementation.
• Incentives are sectorial, with independent motivations and initiatives.
• Local healthcare information technology (HC IT) market stage drives providers to offer EMR as a module
pack within a hospital information system (HIS) solution.
• Very little national or regional incentives. In some states and some cities only.
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were assessed. The five high-income countries achieved
high adoption, while the two middle-income countries
had lower EMR adoption rates. In Italy, Korea, Rep. and
Taiwan, EMR implementation started more than 10 years
ago and several governmental initiatives were in place to
increase uptake. Also, research using EMR data was
already published by the time of this study [23–28]. In
the Middle-Eastern countries, Saudi Arabia and UAE,
EMR research was relatively novel but government in-
centives were in place. Government funding has been
reported as one of the main drivers for EMR adoption
[18] and our findings support this. In the countries with
lower adoption rates, government funding was present
only in South Africa, but lacking in Brazil. However,
several barriers towards EMR use were identified in
these countries.
Different factors influenced the feasibility of data
extraction for secondary uses, such as EMR adoption,
quality of data, trends and incentives for EMR imple-
mentation and information governance procedures.
Table 4 shows that it seems more feasible to extract
EMR data for research in Italy, Saudi Arabia, Korea,
Rep., Taiwan and UAE, but less feasible in Brazil and
South Africa.
Barriers towards EMR use have been extensively stud-
ied [4, 6, 20, 21, 29], though there remains limited
evidence that can provide an understanding of the or-
ganisational context and process changes. The barriers
found in our study were mostly in line with those previ-
ously reported in other countries. A systematic review
on the costs and benefits of health information technol-
ogy found that costs and perceived resistance by physi-
cians were the main barriers towards EMR adoption
[13]. In our study, costs were reported as a barrier, but
resistance by physicians was not mentioned by our inter-
viewees, which may have been because we interviewed
stakeholders who knew about EMR in their setting
and these stakeholders may have been less resistant
towards EMR use.
Another review reported on concerns about patient
privacy and legal barriers to the use of EMR [21]. Even
though European countries have comprehensive national
privacy laws and information commissioners, in our
study concerns about data security were still mentioned
in the European countries. If a study with data from EMR
is undertaken at a single institution, approvals can be eas-
ily manageable. However, when a regional or national
study is undertaken the approvals become hard to manage
[7], which interviewees also reported in our study.
A limitation of the study is its commissioned nature,
which meant that the included countries and the ques-
tionnaire were chosen by the client. This also meant that
a purposive sample was included and that some
countries (Mexico and Czech Republic) only had one
interviewee. We used a rapid approach and asked partic-
ipants to respond within a short period of time (two
weeks) and thus the answers were self-reported when no
interview could take place. However, this approach
allowed us to share up-to-date and new insights into the
information governance procedures and adoption and
quality of EMR in a number of countries.
Another limitation is that this study only assessed three
aspects of data quality: type of fields, fill rates and closed-
ended fields. Other aspects of EMR systems, which vary
on multiple dimensions, could not be assessed, including
the details (clinical data, non-clinical data), data source,
level of complexity, incorporation of other documents
(digital images, scanned documents) timeframe (single
occasion to complete health record) and extent of in-
tegration with other services [5]. Nevertheless, this
study provides an important overview of the most
relevant aspects of the quality of EMR for extracting
data for research.
Future research in this area could explore other
aspects of data quality and adoption. Both benefits, in-
cluding data security, legibility, accessibility, complete-
ness, comprehensiveness, efficiency, and risks such as
paper persistence, patient disengagement, insecure data,
increased time, and increased costs should be assessed
[5]. Research is also needed on the views of patients and
the public about data from their EMR being used in
areas not directly related to providing them with clinical
care [30, 31].
Conclusions
This is the first international comparative study to shed
light on the information governance procedures and
adoption of EMR in several countries. We hope it will
inform the discussions and development of policies that
aim to accelerate adoption of EMR and seizing of the
rich potential for the secondary uses of data arising from
them. Data from EMR have considerable scope to im-
prove the safety, quality and efficiency of healthcare; as
well as being a valuable resource for research, particu-
larly when linked to other data such as mortality records
or genetic data. It is therefore important that countries
work towards making these data more accessible for
their secondary uses. At the same time confidentiality of
the data should be ensured. Also any concerns that pa-
tients and the public might have about their data being
used for purposes other than providing them with clin-
ical care should be addressed. Last but not least, it is
very important also to establish mechanisms for use of
such data at national levels. They provide an invaluable
source for policymakers, for measurement of disease
burden and for planning of investments in healthcare as
well as for pharmaceuticals to ensure safe and effective
use of medications.
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Table 4 Recommendations regarding the feasibility of data extraction from EMR for secondary uses
Countries Feasible to extract data from EMR? Factors influencing recommendation
EMR adoption Quality of data Implementation trends
and incentives
Information
governance
procedures
Other
Italy More feasible, optimal regions
might include Abruzzo, Piemonte,
Lazio, Lombardia and Trento.
High adoption, particularly in
general physician clinics.
High fill rates. Already
good linkage between
EMR systems in general
physician practices and
hospitals.
Funding incentives. Clear process. Could
take a long time.
Existing research using
EMR extracted data.
Saudi Arabia More feasible, data from public sector. High adoption in governmental
facilities.
High fill rates.
Comprehensive data
available.
Increasing implementation.
Future plans for unified EMR.
Clear process for
public sector, but
not for private
sector. Could take a
long time.
Health research oriented
facilities exist.
Korea, Rep. More feasible. High adoption, particularly in
general physician clinics and tertiary
hospitals. Low fragmentation of
providers in clinics, higher in
hospitals.
High fill rates.
Comprehensive data
available. Consistency of
EMR data.
Increasing implementation.
Funding incentives.
Clear process.
Moderately quick.
Existing research using EMR
extracted data including
diabetes research.
Taiwan More feasible, optimal setting may
be larger cities or institutions.
High adoption nationwide. High fill rates.
Comprehensive data
available.
Increasing implementation.
Funding incentives.
Clear process.
Variable time.
Existing research using
EMR extracted data.
UAE More feasible, optimal setting in
might include Health authority
Abu Dhabi (HAAD) affiliated
healthcare facilities (SEHA).
High adoption in general physician
clinics and hospitals.
High fill rates.
Comprehensive data
available.
Increasing implementation.
Different incentives in the
public sector.
Clear process in
SEHA facility.
Moderately quick.
Brazil Less feasible Overall low adoption, centered in a
few hospitals and clinics. High
fragmentation of providers.
Inconsistency of EMR data
between sites.
Slowly increasing
implementation.
Government initiatives are
poor and just beginning.
Clear process. Could
take a long time.
Public systems are very
difficult to access for
research; clinic by clinic
basis in the private sector.
South Africa Less feasible, but when done an optimal
setting may be major tertiary institutions
in the Western Cape region or directly
with the Ministry of Health.
Overall low adoption, higher
adoption in private general
physician clinics.
Available data are likely to
be of modest quality and
quantity.
Rapid increase. Attempts
for interoperability.
No clear process.
Takes a long time.
The use of EMR extracted
data is very difficult.
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